Spartan Bioscience Announces Alere Inc. as Exclusive Distributor for Germany, Austria and Switzerland
Published: Jan 10, 2011
(BUSINESS WIRE)--Spartan Bioscience Inc., a privately held molecular diagnostics company that develops, manufactures, and markets DNA testing systems for on-demand applications, today announces an exclusive distribution agreement with Alere GmbH for distribution of the Spartan RX CYP2C19 in Germany, Austria and Switzerland. Alere GmbH is a subsidiary of Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management. Alere will concentrate its efforts on reaching customers in surgery suites and catheterization labs within hospitals and other medical centers.